Dr Hoenle AG (XTER:HNL) Change In Receivables : €1.6 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG Change In Receivables?

Dr Hoenle AG's change in receivables for the quarter that ended in Dec. 2023 was €4.0 Mil. It means Dr Hoenle AG's Accounts Receivable declined by €4.0 Mil from Sep. 2023 to Dec. 2023 .

Dr Hoenle AG's change in receivables for the fiscal year that ended in Sep. 2023 was €0.8 Mil. It means Dr Hoenle AG's Accounts Receivable declined by €0.8 Mil from Sep. 2022 to Sep. 2023 .

Dr Hoenle AG's Accounts Receivable for the quarter that ended in Dec. 2023 was €11.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Dr Hoenle AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 44.42.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dr Hoenle AG's liquidation value for the three months ended in Dec. 2023 was €-39.6 Mil.

Dr Hoenle AG Change In Receivables Historical Data

The historical data trend for Dr Hoenle AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG Change In Receivables Chart

Dr Hoenle AG Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Change In Receivables

Get a 7-Day Free Trial

6.52

2.67

-1.26

-2.74

0.76

Dr Hoenle AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															3.14	-1.27	0.18	-1.29	3.97

Dr Hoenle AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.6 Mil.

Dr Hoenle AG (XTER:HNL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Dr Hoenle AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	11.58	/	23.787	*	91
=	44.42

2. In Ben Graham's calculation of liquidation value, Dr Hoenle AG's accounts receivable are only considered to be worth 75% of book value:

Dr Hoenle AG's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8.553	-	74.514	+	0.75 * 11.58	+	0.5 * 35.282
=	-39.6

Dr Hoenle AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Hoenle AG (XTER:HNL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

HNL:Germany HNL:Germany

Address

Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205

Website

https://www.hoenle.de

Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines